CR UK streams £60m into tackling global cancer

23rd January 2019


Cancer Research UK has pledged to tackle global cancer challenges with £60 million funding.

The charity says it is funding three major new international research initiatives on the microbiome, chronic inflammation and why some cancers are specific to certain tissues and not others.

The multidisciplinary teams of scientists, who have been awarded almost £60 million collectively, come from across North America, the UK and Europe, and Israel and plan to come together to explore these challenges, which are currently some of the biggest in cancer research.

The move to bring these teams together is part of Cancer Research UK's Grand Challenge project, which aims to find novel ways of treating cancer and develop new options to prevent cancer developing in high-risk patients.

Dr Iain Foulkes, Cancer Research UK’s executive director of research and innovation, said: “Individually, these research teams are among the best in the world in their respective fields. By bringing them together across borders, Grand Challenge is enabling these teams to think bigger and establish new and exciting collaborations. The scale of the funding reflects the opportunity we see in harnessing their ability to understand and tackle cancer.”

These five-year research programmes will investigate how billions of microorganisms living in our bodies, called the microbiome, could be manipulated to treat bowel cancer; find new ways to tackle cancers linked to chronic inflammation; and develop a deeper understanding of why cancers develop in some tissues but not in others.

The funding for these new projects comes from Cancer Research UK directly and with support from The Mark Foundation for Cancer Research, based in New York, which is providing £10 million to the project

- Sep 26, 2018

What is a pharmaceutical product?

A pharmaceutical product or medicine is defined as a substance or mixture of substance manufactured, sold or supplied for use in the treatment, mitigation of any abnormal physical or physiological state or its symptom; or altering, modifying, correcting or restoring any organic function, in human beings or in animals, that is subject to control by pharmaceutical legislation. Public health concerns demand that the pharmaceutical product exported/imported must conform to international safety standards.


Two factors determine whether or not a product falls under the Pharmaceutical category:

  1. The usage claims made in relation to the product. This is the description about what the product is used for. It usually appears at the back of the products or as a pamphlet inside the packaging of the product. If the usage is intended for medical purposes, then it falls into the Pharmaceutical category.
  2. The composition of the product. If a product includes a drug substance, then it is classified as a pharmaceutical product. A drug substance is one, which is gain used for the treatment or prevention of a disease/disorder.



India currently exports various pharmaceutical/medical products like drug intermediates, Dosage Formulations (FDFs), Bio-Pharmaceuticals, etc. to various parts of the world. The country now ranks 3rd in terms of volume of pharmaceutical products’ production (10% of global share) and 14th largest by value. Looking at this, the world is now considering India as a profitable venue to both market and manufacture its pharma products. Pharma export market in India is very potential for the buyers spread the world over for procuring their required pharmaceutical formulations in all the available dosage forms.

The application for an export permit for a Pharmaceutical product usually entails the following:

  • Generic name or International Non-proprietary Name (INN)
  •  Strength/dosage form
  • Name and strength of each ingredient
  • Trade name or proprietary name; if any
  • Pharmacopoeia* specification of the medicine, wherever applicable
  •  Total quantity to be exported
  •  Name and address of the exporter
  • Name and address of the manufacturer
  • Name and address of consignee
  • Country of consignee


* Pharmacopoeia in its modern technical sense, is a book containing directions for the identification of compound medicines, and published by the authority of a government or a medical or pharmaceutical society. (source: wiki) 

Before applying for an export permit, make sure you have applied for an export license as well. Make sure that you follow international drug regulations of the importing country as well. If they are not up to the standards of the importing country, your products could be refused entry and seized by customs officials. It might be even considered illegal importation.